Pharmaceuticals

Amplyx Corporate Office

Amplyx Pharmaceuticals often referred to as simply Amplyx, is a San Diego-based company that develops advanced therapeutic solutions for life-threatening fungal infections.

The company has created several new classes of medicines to treat fungal infections that do not respond to other types of medication.

In October 2015, the company received $50 million in Series B funding for Phase 2 development of these drugs.

In May 2020, the company raised $53 million in Series C funding for clinical trials involving humans.

Pfizer Pharmaceuticals was one of the biggest participants.

In June 2020, Amplyx announced that it had appointed Chris LeMasters as Chief Operating Officer.

LeMasters stated ” “The emerging COVID-19 pandemic has provided a reminder of the critical threat of opportunistic microbial infections in patients who have become immunocompromised,” said LeMasters. “There is a dire need for novel and effective treatments, both for these superinfections as well as infections impacting patients whose immune systems are compromised through other means, like anti-cancer therapies.”

Amplyx maintains a corporate office in San Diego, California.

Amplyx

Amplyx Pharmaceuticals often referred to as simply Amplyx, is a San Diego-based company that develops advanced therapeutic solutions for life-threatening fungal infections.

The company has created several new classes of medicines to treat fungal infections that do not respond to other types of medication.

In October 2015, the company received $50 million in Series B funding for Phase 2 development of these drugs.

History

In May 2020, the company raised $53 million in Series C funding for clinical trials involving humans.

Pfizer Pharmaceuticals was one of the biggest participants.

In June 2020, Amplyx announced that it had appointed Chris LeMasters as Chief Operating Officer.

Amplyx maintains a corporate office in San Diego, California.

Boots UK Corporate Office

John Boots founded Boots stores in Nottingham, UK, back in 1849. When John passed away in 1860, his 10-year old son Jesse helped his mother continue to operate the herbal medicine shop. In 1888 the company incorporated as the Boots Pure Drug Company.

Today, Boots is one of the largest retailers in the UK and Ireland, both in revenue and number of shops, with at least 2,500 locations. The company offers health and beauty products, hearing care services, optician services, and prescription drugs.

n 2009 Boots Superintendent Pharmacist Paul Bennett was interviewed by the House of Commons Science and Technology Committee about the company’s sale of homeopathic medicines. He told the committee that the company had no evidence to suggest that homeopathic medicines are efficacious but Boots sold them anyway, for reasons of “consumer choice”. The comments attracted significant media attention.

In July 2017, the British Pregnancy Advisory Service revealed that Boots was selling the “morning after” pill, which is an emergency contraceptive medication, at four times the cost. The company refused requests to join rival pharmacy retail chains to cease profiting financially from this medication. In a written response to BPAS, Boots revealed that they were frequently contacted by individuals who disapproved of the dispensing of such medication, which might be viewed as “incentivising inappropriate use”, an assertion which campaigners described as “insulting and sexist”. By the end of January 2018, Boots confirmed that it was now offering the discounted price on this medication in all of its pharmacies.

The company announced that at the end of September 2019, they would start charging for delivery service. Customers are outraged, claiming that Boots is putting a tax on sick people who require medication and can’t get to the pharmacy.

A makeup artist is claiming racial discrimination after discovering that only products for black haircare contained security tags to prevent theft.

The head office remains in Nottingham, where is has been for 170 years.

Boots

History

A makeup artist is claiming racial discrimination after discovering that only products for black haircare contained security tags to prevent theft.

The head office remains in Nottingham, where is has been for 170 years.

Bayer Corporate Office

Bayer can trace its roots all the way back to 1863. The company was founded in Barmen, Germany, by Fredrich Bayer and his partner, Johann Friedrich Weskott. Corresponding to his education, Friedrich Bayer was responsible for commercial tasks at the young company. Wescott had an apprenticeship as dyer, which gave him knowledge in chemistry.

After moving several times, the company came up with their logo of the Bayer “cross”, which is still used today. In 1899, the company received a trademark for the word aspirin and began selling tablets in drug stores. The company also sold heroin as a cough suppressant The word Heroin was a company trademark until after WWI.

Today, Bayer is mainly known for aspirin and other pharmaceutical items, even though the company has expanded into other areas including fertilizer, vitamins, and, with the acquisition of Monsanto in 2016 for $66 Billion, GMO seeds.

The company also has a pet care division, which markets flea, tick, and heartworm medication for dogs and cats, as well as prescription drugs for horses, cattle, and family pets.

Bayer’s main headquarters is located in Germany, as well as headquarter extensions in almost every continent. In the US, the corporate office is located in Whippany, New Jersey.

Bayer

History

The company also has a pet care division, which markets flea, tick, and heartworm medication for dogs and cats, as well as prescription drugs for horses, cattle, and family pets.

Bayer’s main headquarters is located in Germany, as well as headquarter extensions in almost every continent. In the US, the corporate office is located in Whippany, New Jersey.

Akorn Corporate Office

Akorn Pharmaceuticals, originally founded in 1948 as Taylor Pharmacy, is a specialty generic pharmaceutical company which develops, manufactures, and markets specialized generic and branded pharmaceuticals, including over-the-counter (OTC) drugs.

The company operates in two basic segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription drugs in various dosage forms. The Consumer Health sector manufactures and markets OTC products for the treatment of dry eyes under the TheraTears brand, as well as other OTC consumer health products, including Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In April of 2017, the company was acquired by Fresenius for $4.3 billion.

Akorn is listed as #19 on the Fortune 100 list of Fastest Growing Companies in America. In 2016, the company had annual revenue of $4.4 billion and a three year growth rate of 93 percent. The company is publicly traded on the NASDAQ under the ticker symbol: AKRX

Akorn

History

Mylan Pharmaceuticals Corporate Office

Mylan was founded in 1961 as Milan Pharmaceuticals by Milan Puskar and Don Panoz in West Virginia. The company began as a pharmaceutical distributor.

In 1966 the company received approval to begin manufacturing penicillin.

The company went public on the NYSE in 1973 under the ticker symbol MYL.

In 1980 Mylan discontinued private-label manufacturing and began marketing its markets under the company’s own “Mylan-labeled” brand.

In 2016, Mylan’s pricing of the EpiPen, an epinephrine injection that is a lifesaving drug for those with severe allergic reactions, became controversial and was widely referred to as “price gouging”. As a result, investigations were opened into whether Mylan had misclassified the product under the Medicaid Drug Rebate Program. In October 2016, Mylan settled these investigations with the U.S. Department of Justice, agreeing to pay $465 million in fines.

Today Mylan Pharmaceuticals is one of the largest manufacturers of generic drugs in the world. The company’s customers are distributors, wholesalers, retailers, and government agencies in 150 countries worldwide.

The company regularly uses robots for faster drug analysis. Prices have plunged for generic drugs and competition is getting increasingly fierce for many U.S. generic drugs. This has contributed to a 22 percent year-over-year decline for its North American business.

Mylan Pharmaceuticals is a member of the S&P 500, is #377 in the Fortune 500, has 35,000 employees, and had $7.13 billion in revenue in 2013. Headquarters are located in Canonsburg, Pennsylvania.

Mylan Pharmaceuticals

Mylan was founded in 1961 as Milan Pharmaceuticals by Milan Puskar and Don Panoz in West Virginia. The company began as a pharmaceutical distributor.

In 1966 the company received approval to begin manufacturing penicillin.

History

The company went public on the NYSE in 1973 under the ticker symbol MYL.

In 1980 Mylan discontinued private-label manufacturing and began marketing its markets under the company’s own “Mylan-labeled” brand.

Mylan Pharmaceuticals is a member of the S&P 500, is #377 in the Fortune 500, has 35,000 employees, and had $7.13 billion in revenue in 2013. Headquarters are located in Canonsburg, Pennsylvania.